STERIS plc (NYSE:STE) Files An 8-K Results of Operations and Financial Condition

STERIS plc (NYSE:STE) Files An 8-K Results of Operations and Financial Condition

Story continues below

ITEM2.02.

Results of Operations and Financial
Condition.

On May9, 2017, STERIS plc issued a press release announcing
financial results for the three and twelve month periods ended
March31, 2017. A copy of this press release is attached hereto as
Exhibit 99.1.

The information contained in this Item2.02 of this Current Report
on Form 8-K, including Exhibit 99.1 attached hereto, is being
furnished to the Securities and Exchange Commission and shall not
be deemed to be filed for purposes of Section18 of the Securities
Exchange Act of 1934 or otherwise subject to the liabilities of
that Section. Furthermore, the information contained in this
Item2.02 of this Current Report on Form 8-K shall not be deemed
to be incorporated by reference into any registration statement
or other document filed to the Securities Act of 1933.

ITEM9.01. Financial Statements and Exhibits.
(d) Exhibits.
Exhibit

No.

Description

99.1 Press Release issued by STERIS plc on May 9, 2017 announcing
financial results for the three and twelve month periods
ended March31, 2017.

2


About STERIS plc (NYSE:STE)

STERIS plc provides infection prevention and other procedural products and services. The Company operates through four segments: Healthcare Products, which offers infection prevention and procedural solutions for healthcare providers, including capital equipment and related maintenance, and installation services, as well as consumables; Healthcare Specialty Services, which provides a range of specialty services for healthcare providers, including hospital sterilization services, instrument and scope repairs, and linen management; Life Sciences, which offers capital equipment and consumable products, and equipment maintenance and specialty services for pharmaceutical manufacturers and research facilities, and Applied Sterilization Technologies, which offers contract sterilization and laboratory services for medical device and pharmaceutical customers and others. Its Corporate and other segment includes the Defense and Industrial business unit.

STERIS plc (NYSE:STE) Recent Trading Information

STERIS plc (NYSE:STE) closed its last trading session down -0.41 at 75.30 with 651,719 shares trading hands.

An ad to help with our costs